Trevi Therapeutics (TRVI) Ownership - Who owns Trevi Therapeutics?

20 days until earnings call

Profile

Industry
Pharmaceuticals Major
Address
195 Church Street
Phone
+1 203 304-2499
Employees
25
Web
https://www.trevitherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
187.36M
P/E Ratio
N/A
Total Cash
72.82M
Projected Growth
N/A
Total Debt
1.27M
Revenue
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
1.03
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TRVI
Capitalization
187M
P/E Ratio
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
72.8M
Total Cash/Share
1.03
Total Debt
1.27M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
72.3M
P/B Ratio
2.59
Cash Flow
N/A
Earnings
-0.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
69K
Current Ratio
14.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-33.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.47
Shares Held By Institutions
173M
Shares Outstanding - Current
70.4M
Total Liabilities
6.23M
Total Volume MTD
N/A
Value
N/A
Gain YTD
98.507
View a ticker or compare two or three
TRVI
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer and manufacturer of neurological products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
195 Church Street
Phone
+1 203 304-2499
Employees
25
Web
https://www.trevitherapeutics.com